Subscribe
shutterstock-117501220-web
19 March 2014Patents

EPO staff set to strike for seven days

Staff at the European Patent Office (EPO) will strike for seven days, starting this week, it has been confirmed.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
Anger as EPO president rejects latest strike
4 June 2014   A planned strike at the European Patent Office has been rejected by its president, causing further unrest among EPO workers, WIPR can reveal.
Patents
EPO facing more strike action
28 May 2014   Further strike action has been planned at the headquarters of the European Patent Office as unrest among workers continues to grow.


Editor's picks

Ferrari wins Testarossa classic car case at EU court
Trademarks
Ferrari wins Testarossa classic car case at EU court
2 July 2025

Editor's picks

Trademarks
Ferrari wins Testarossa classic car case at EU court
2 July 2025
Patents
A step too far? Why Stewart’s approach is dividing opinion
20 June 2025
AI
What is an ‘AI training declaration’ and who might need one?
20 June 2025
Future of IP
‘Sad beige’ lawsuit shows how hard it is for influencers to stand out
20 June 2025
Trademarks
Creative licence: Inside the LEGO Group’s Asia playbook
16 June 2025
Copyright
‘Cynical and bewildering’: UK omits copyright protections in Data Bill
13 June 2025

More articles

Lord Justice Birss to become chancellor of the High Court
‘We created law’: G1/24 and the creation of the ‘diamond standard’
Tech litigators join Hogan Lovells’ Paris practice from A&O Shearman
How in-house patent pros are ‘enablers of innovation’
Smart IP for startups: how to avoid the common traps
Defending the realm: How a key MoD supplier crafts its IP strategy
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
BREAKING: Key post-sale confusion ruling ‘welcomed’ by brand owners